Anti-Aging · Reference
Liposomal Glutathione vs Injectable Glutathione: Evidence, Absorption, Cost and Which Fits
This page explains each form on its own terms, puts them side by side with plain oral and IV glutathione, covers what the research does and does not show, side effects, FDA status, how Pepti doses the injection, what it costs, and who tends to suit which.
Treatments mentioned
Liposomal glutathione is an oral supplement in which glutathione is wrapped in tiny fat-based spheres meant to help it survive digestion, while injectable glutathione is a prescription solution injected under the skin so it never passes through the gut. Neither route is proven better. Oral glutathione has the strongest trial evidence: a six-month randomized trial found 1,000 mg a day raised body glutathione stores by 30 to 35 percent, and a 2018 pilot in 12 adults reported similar rises with a liposomal form. There are no randomized trials of subcutaneous glutathione, and whether a small injection raises tissue glutathione has not been measured. Pepti prescribes the injection, not liposomal supplements, and compounded glutathione is not FDA approved.
This page explains each form on its own terms, puts them side by side with plain oral and IV glutathione, covers what the research does and does not show, side effects, FDA status, how Pepti doses the injection, what it costs, and who tends to suit which.
Liposomal Glutathione vs Injectable Glutathione
The short answer
| If what you want is | The usual choice | What it involves | Price |
|---|---|---|---|
| The route with the most trial evidence for raising body stores | Oral glutathione, standard or liposomal | Daily capsules or liquid, sold as supplements | Not supplied by Pepti |
| Glutathione that bypasses the gut, at home | Glutathione injection | 1,000 mg in a 5 mL vial; 0.41 mL under the skin three times weekly | $199/mo |
| A precursor approach by mouth | Glycine plus N-acetylcysteine | The building blocks, taken orally | Not supplied by Pepti |
| A large dose by vein | IV glutathione at a clinic | A drip or push into a vein | Set by the clinic; not offered by Pepti |
Pepti's price is all-in, covering medication, physician review, refill management and shipping, with no separate membership fee. Pepti is cash-pay and does not bill insurance.
Liposomal Glutathione vs Injectable Glutathione
Glutathione itself, briefly
Glutathione is a tripeptide of three amino acids, glutamate, cysteine and glycine, and every nucleated cell makes it. It is the most abundant small thiol in the body and the main antioxidant inside cells; a 2013 review in Biochimica et Biophysica Acta notes that cysteine supply usually caps how much a cell can make. The active form is reduced glutathione (GSH). When it neutralizes a reactive molecule it becomes glutathione disulfide (GSSG), and an enzyme recycles it using NADPH. It is also the cofactor that lets the liver attach and clear reactive drug breakdown products. Because glutathione does not bind a receptor, the real question for any product is not what glutathione does, but whether giving more from outside changes anything, and by which route. The full reference is what is glutathione.
Liposomal Glutathione vs Injectable Glutathione
Liposomal glutathione on its own terms
What it is
A liposome is a microscopic sphere with a fat-based outer layer, similar to a cell membrane, that can carry a substance inside it. Liposomal glutathione is reduced glutathione packaged in liposomes and taken by mouth, usually as a liquid or capsule. The idea is to protect glutathione from being broken down into its amino acids in the gut before it can be absorbed. It is sold as a dietary supplement, without a prescription. Supplements are not reviewed and approved by the FDA before sale the way drugs are, so the amount and form in a product depend on its manufacturer.
Why packaging matters for oral glutathione
The question liposomes are meant to answer is real. A 1992 paper in the European Journal of Clinical Pharmacology gave seven volunteers a single oral dose of glutathione and found plasma glutathione did not rise. A 2011 randomized trial in the Journal of Alternative and Complementary Medicine gave 40 adults 500 mg twice daily for four weeks and found no change. Those results are why oral glutathione was long considered poorly absorbed.
What human data exists
Study Form Who What was reported European Journal of Nutrition, 2015 Standard oral, 250 or 1,000 mg daily 54 non-smoking adults, six months, randomized and placebo-controlled High-dose group 30 to 35 percent above baseline in red cells, plasma and lymphocytes; natural killer cell activity more than doubled versus placebo at three months; back to baseline a month after stopping European Journal of Clinical Nutrition, 2018 Liposomal oral 12 adults, pilot Similar rises in body glutathione Journal of Alternative and Complementary Medicine, 2011 Standard oral, 500 mg twice daily 40 adults, four weeks, randomized No change European Journal of Clinical Pharmacology, 1992 Standard oral, single dose 7 volunteers No rise in plasma glutathione The honest reading: oral glutathione probably raises body stores over months, a single dose does not, and four weeks may be too short to show it. The liposomal evidence is one small pilot, which reported rises similar to the six-month standard oral trial. It does not establish that liposomal is better than standard oral glutathione, because the two were not compared in the same trial, and it does not show any clinical outcome.
Liposomal Glutathione vs Injectable Glutathione
Injectable glutathione on its own terms
What it is
A sterile solution of reduced glutathione, compounded by a licensed pharmacy and injected into the fat layer of the abdomen or thigh. At Pepti the vial is 5 mL at 200 mg/mL (1,000 mg), and the directions are 0.41 mL (41 units on a U-100 insulin syringe) three times per week. That is 82 mg per dose by label arithmetic, twelve doses per vial, about four weeks. It is injected under the skin and must never be injected into a vein.
Why people choose injection
The case for injection is bypassing breakdown in the gut entirely. That is a sound pharmacological argument, and it is the whole argument: it has not been tested in a trial.
What human data exists
There are no randomized controlled trials of subcutaneous glutathione. The route rests on the pharmacology of the molecule, on tolerability shown in intravenous trials at far higher doses, and on prescribing experience. A 1991 study in the European Journal of Clinical Investigation found high-dose intravenous glutathione rose sharply in plasma and cleared within minutes to an hour: a brief pulse, then delivery of its amino acids. Whether a small subcutaneous dose behaves the same way, or raises tissue glutathione at all, has not been measured. A prescriber who says subcutaneous glutathione "works like an IV" is extrapolating, and so is one who says it does not.
Liposomal Glutathione vs Injectable Glutathione
IV glutathione, for context
Intravenous glutathione is where the controlled clinical data lives, and the results are specific:
| Study | Who | What was reported |
|---|---|---|
| Journal of Clinical Oncology, 1995 | People with advanced gastric cancer receiving cisplatin | Less peripheral nerve damage, without loss of the chemotherapy's effect |
| Progress in Neuro-Psychopharmacology and Biological Psychiatry, 1996 | Nine people with early Parkinson's disease, open-label | A 42 percent fall in disability scores, without a control group |
| Movement Disorders, 2009 | 21 people with Parkinson's, 1,400 mg three times weekly for four weeks, randomized and placebo-controlled | Well tolerated; no significant difference from placebo |
The cisplatin result applies to people receiving that drug under oncology care. When the Parkinson's question was tested properly, the effect did not hold. A 2017 phase IIb trial of intranasal glutathione in 45 Parkinson's patients also found every arm improved, placebo included. IV glutathione is a clinic service, and Pepti does not offer it.
Liposomal Glutathione vs Injectable Glutathione
Head to head
| Liposomal glutathione | Injectable glutathione | |
|---|---|---|
| What it is | Reduced glutathione in fat-based spheres, taken by mouth | Reduced glutathione in sterile solution |
| Route | Oral | Under the skin |
| Passes through the gut | Yes, protected by the liposome | No |
| Prescription | No; sold as a supplement | Yes |
| Who makes it | Supplement manufacturers | A licensed compounding pharmacy, to a prescription |
| Randomized trials | One small liposomal pilot (2018), plus the standard oral trials | None for the subcutaneous route |
| Shown to raise body stores | Reported in a 12-person pilot | Not measured |
| Dosing frequency | Daily in the oral trials | Three times weekly at Pepti |
| Common side effects | None reported in the oral trials as a safety signal | Injection-site redness, mild soreness, bruising |
| Lot testing | Depends on the manufacturer | Pepti publishes lot results at /quality/lab-results |
| Head-to-head trial | None | None |
| At Pepti | Not supplied | $199/mo, all-in |
The real difference is evidence versus route
Liposomal glutathione has a small amount of direct human evidence that it raises body stores, and it sits on top of a larger standard-oral literature. Injectable glutathione has the more direct route and the accountability of a prescription and a pharmacy, but no trial at all. Neither has trial evidence for disease outcomes in a general population. Anyone claiming one has been shown to beat the other is describing a study that has not been done. It is a fair question to ask your physician why injection is being recommended over an oral form.
Liposomal Glutathione vs Injectable Glutathione
What the evidence shows, honestly
Glutathione is unusual among wellness compounds because it has real randomized human trials, but they were done by mouth, by vein, by nose and on the skin, not by the under-the-skin injection that is usually prescribed. Oral use over months raises body stores, and a liposomal pilot reported similar rises. Intravenous use reduced nerve damage in one chemotherapy trial and did not beat placebo in Parkinson's disease. The strongest controlled evidence that restoring low glutathione changes physiology did not use glutathione at all: a 2023 randomized trial in the Journals of Gerontology gave 24 older adults glycine plus N-acetylcysteine for 16 weeks and reported corrected glutathione deficiency, lower oxidative-stress markers, and improved gait speed and grip strength. "Detox" in the marketing sense, a general cleanse, is not something any trial has measured for any form. The benefit-by-benefit picture is in glutathione benefits.
Liposomal Glutathione vs Injectable Glutathione
Side effects
Oral and liposomal. The six-month oral trial reported no safety signal.
Injectable. Glutathione has an unusually deep tolerability record for a compounded injectable: the 2009 intravenous trial reported adverse events similar to placebo at 1,400 mg three times weekly.
| How often | What is reported with the injection | What to do |
|---|---|---|
| Common | Injection-site redness, mild soreness, occasional bruising | Rotate sites between abdomen and thigh |
| Uncommon | Brief light-headedness or nausea after a dose | Report it to your care team |
| Caution | Asthma | Tell your physician; inhaled glutathione has been reported to provoke bronchospasm |
| Stop and call | Fever, chills or shaking shortly after a dose | Not an expected side effect; contact your physician the same day |
| Stop and get help | Facial or throat swelling, widespread rash, difficulty breathing | Call 911, then tell your physician |
The fever-and-chills row has a history. On 7 June 2019 the FDA warned compounders about a dietary-supplement-grade glutathione powder that had been used to make intravenous injections: testing found bacterial endotoxin at up to five times the appropriate limit, and eight patients had reactions ranging from chills and nausea to low blood pressure and hospitalization. The problem was the ingredient, not glutathione. It is the clearest illustration of why supplement-grade material and sterile injectables are different things, and why an injection must come from a pharmacy accountable for endotoxin testing.
Glutathione is not used in pregnancy or breastfeeding, where safety data is absent. It is a cofactor in the metabolism of many drugs, and there is no established interaction list for the injection, so list everything you take, supplements included. Glutathione is not named on the 2026 WADA Prohibited List, but tested athletes should check with their governing body first.
Liposomal Glutathione vs Injectable Glutathione
Where glutathione stands with the FDA
As of the FDA's document dated 14 May 2026, glutathione is in 503A Category 1, "Bulk Drug Substances Under Evaluation," under which state-licensed pharmacies may compound it while the FDA completes its review. It was never in Category 2, the safety-concern category, so the April 2026 peptide removals did not involve it. It is also in Category 1 of the separate 503B list dated 21 March 2025. Compounded glutathione is not FDA approved, and supplements, liposomal or otherwise, are not FDA approved either.
Liposomal Glutathione vs Injectable Glutathione
Dosing and logistics at Pepti
| Detail | Glutathione injection |
|---|---|
| Product | Glutathione |
| Vial | 5 mL multi-dose vial, 200 mg/mL (1,000 mg) |
| Directions | 0.41 mL (41 units) subcutaneously three times per week |
| Glutathione per dose | 82 mg (200 mg/mL x 0.41 mL) |
| Doses per vial | 12, about four weeks |
| Format | Vial and syringe only |
| Price | $199/mo, all-in |
Your physician sets your directions after reviewing your intake, and your exact dose is printed on the vial. Refills run every 28 days, one vial per fill. The vial arrives as a solution ready to use, with sterile syringes and alcohol prep pads, shipped refrigerated with ice packs. Reduced glutathione oxidizes on contact with air, so keep the vial cold and capped, and follow the beyond-use date on the label, which runs from first puncture.
Liposomal Glutathione vs Injectable Glutathione
Who suits which
Liposomal or standard oral glutathione
Oral glutathione suits someone who wants the route with the most trial evidence for raising body stores, prefers not to inject, and is comfortable choosing a supplement without a prescription. The six-month trial suggests it takes months, and that levels fall back within a month of stopping.
Injectable glutathione
The injection suits someone who wants a prescribed, pharmacy-compounded product that bypasses the gut, with a physician who has reviewed their history, and who understands that the subcutaneous route has no trials. It is often prescribed alongside NAD+ Injection ($249/mo); see NAD+ benefits.
Something else
Situation What makes more sense Skin tone is the goal The evidence is oral and topical, small and short; Pepti does not prescribe glutathione for skin lightening. See glutathione for skin Skin structure is the goal GHK-Cu has the more skin-specific research Immune support is the goal Thymosin alpha-1 has a much larger human evidence base Fatigue you have not had checked The common causes first; see peptides for energy and fatigue Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account.
Liposomal Glutathione vs Injectable Glutathione
Where to get glutathione injections prescribed
Glutathione injections cannot be bought legitimately without a prescription, and the 2019 FDA alert shows what happens when the ingredient is wrong. The prescription route:
- Complete a free online intake covering your history, medications and what you want help with, including any oral glutathione you take.
- A physician licensed in your state reviews it, usually within 24 hours.
- If it is appropriate, a PCAB-accredited, FDA-registered US 503A pharmacy compounds it to that prescription. Lot test results are published at /quality/lab-results.
- It ships refrigerated with your directions printed on the vial.
- Your physician stays reachable for questions and dose changes.
Pepti prescribes glutathione in every state except Oklahoma, plus DC Step by step: how to get glutathione prescribed online.
References
What this is based on.
References
- Richie JP Jr, Nichenametla S, Neidig W et al.. Randomized controlled trial of oral glutathione supplementation on body stores of glutathione · Eur J Nutr (2015) · PMID 24791752
- Allen J, Bradley RD. Effects of oral glutathione supplementation on systemic oxidative stress biomarkers in human volunteers · J Altern Complement Med (2011) · PMID 21875351
- Sinha R, Sinha I, Calcagnotto A et al.. Oral supplementation with liposomal glutathione elevates body stores of glutathione and markers of immune function · Eur J Clin Nutr (2018) · PMID 28853742
- Witschi A, Reddy S, Stofer B, Lauterburg BH. The systemic availability of oral glutathione · Eur J Clin Pharmacol (1992) · PMID 1362956
- Aebi S, Assereto R, Lauterburg BH. High-dose intravenous glutathione in man. Pharmacokinetics and effects on cyst(e)ine in plasma and urine · Eur J Clin Invest (1991) · PMID 1907548
- Arjinpathana N, Asawanonda P. Glutathione as an oral whitening agent: a randomized, double-blind, placebo-controlled study · J Dermatolog Treat (2012) · PMID 20524875
- Weschawalit S, Thongthip S, Phutrakool P, Asawanonda P. Glutathione and its antiaging and antimelanogenic effects · Clin Cosmet Investig Dermatol (2017) · PMID 28490897
- Watanabe F, Hashizume E, Chan GP, Kamimura A. Skin-whitening and skin-condition-improving effects of topical oxidized glutathione: a double-blind and placebo-controlled clinical trial in healthy women · Clin Cosmet Investig Dermatol (2014) · PMID 25378941
- Sonthalia S, Daulatabad D, Sarkar R. Glutathione as a skin whitening agent: Facts, myths, evidence and controversies · Indian J Dermatol Venereol Leprol (2016) · PMID 27088927
- Sechi G, Deledda MG, Bua G et al.. Reduced intravenous glutathione in the treatment of early Parkinson's disease · Prog Neuropsychopharmacol Biol Psychiatry (1996) · PMID 8938817
- Hauser RA, Lyons KE, McClain T, Carter S, Perlmutter D. Randomized, double-blind, pilot evaluation of intravenous glutathione in Parkinson's disease · Mov Disord (2009) · PMID 19230029
- Mischley LK, Lau RC, Shankland EG, Wilbur TK, Padowski JM. Phase IIb Study of Intranasal Glutathione in Parkinson's Disease · J Parkinsons Dis (2017) · PMID 28436395
Citations are provided for educational purposes. They do not constitute medical advice. Always discuss any peptide protocol with your prescribing physician.
Common questions
Liposomal Glutathione vs Injectable Glutathione, answered.
Reduced glutathione packaged inside liposomes, microscopic fat-based spheres, and taken by mouth. The packaging is meant to protect it from being broken down in the gut. It is sold as a supplement without a prescription.
No study has compared them. A 2018 pilot in 12 adults reported liposomal glutathione raised body stores, similar to a six-month trial of standard oral glutathione. No trial has measured whether a subcutaneous injection raises body stores at all.
It has one small pilot reporting raised body glutathione, and no trial of any clinical outcome. Standard oral glutathione raised body stores over six months in a randomized trial, while a single dose and a four-week course did not.
That has not been shown. The liposomal pilot and the standard oral trial reported similar rises, but they were separate studies and were never compared directly.
Injection bypasses the gut entirely, and it comes as a prescribed product from a pharmacy accountable for sterility and concentration. The trade-off is that the subcutaneous route has never been tested in a trial, while oral forms have.
At Pepti, 0.41 mL of a 200 mg/mL solution, which is 82 mg per dose, three times per week. Your exact dose is printed on the vial.
IV glutathione has controlled trials, with one positive result in people receiving cisplatin chemotherapy and negative results in Parkinson's disease. High-dose IV glutathione clears from plasma within minutes to an hour. Subcutaneous glutathione has no trials, so there is no basis for ranking them.
Mostly injection-site redness, mild soreness or bruising, sometimes brief light-headedness or nausea. Fever, chills or shaking after a dose are not expected and should be reported the same day. People with asthma should tell their physician.
There is no study of the combination. If you take oral or liposomal glutathione, list it on your intake so your physician reviews everything together.
At Pepti, $199 a month, all-in, covering the medication, physician review, refill management and shipping.
No. Glutathione is in 503A Category 1, under FDA evaluation, and compounded medications are not FDA approved. Liposomal glutathione is a supplement, and supplements are not FDA approved either.
Bloodwork is not required for any Pepti treatment. If your physician wants labs for your care, they'll ask through your account. The free assessment goes to a physician licensed in your state. A consultation does not guarantee a prescription.
Next step
See what a physician recommends for you.
A licensed physician in your state reviews your intake and decides what is appropriate. A consultation does not guarantee a prescription.